Nanoplasmonics Enabling Cancer Diagnostics and Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Plasmonics, photonics, and nanotechnology offer novel approaches for cancer diagnostics and therapeutics.
• Gold nanostars (GNS) exhibit unique properties for enhanced light-matter interactions.

Purpose of the Study:

• To highlight advances in cancer diagnostics and therapeutics using integrated plasmonics, photonics, and nanotechnology.
• To discuss the development and applications of gold nanostars (GNS).
• To explore the combination of GNS with immunotherapy for synergistic effects.

Main Methods:

• Development and characterization of plasmonics-active gold nanostars (GNS).
• Application of GNS in tumor imaging techniques, including two-photon fluorescence and surface-enhanced Raman scattering (SERS).
• Integration of GNS as an adjuvant with immune checkpoint inhibitors for immunotherapy.

Main Results:

• GNS demonstrate significantly amplified thermal generation at resonant wavelengths.
• GNS facilitate effective tumor imaging through various advanced optical techniques.
• The combination of GNS with immunotherapy, termed SYMPHONY, enhances control over long-lasting cancer immunity and metastatic tumors.

Conclusions:

• Gold nanostars are versatile nanomaterials for cancer diagnostics and therapeutics.
• SYMPHONY represents a promising strategy for durable cancer immunity and metastatic tumor control.
• The integration of nanotechnology with immunotherapy offers a powerful platform for advanced cancer treatment.